(Q37159440)

18 August 2017

Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients (English)

1 reference

Dominique Figarella-Branger

18 August 2017

2

object named as

Dominique Figarella-Branger

0 references

Roch Giorgi

5

object named as

Roch Giorgi

1 reference

18 August 2017

Philippe Metellus

1

1 reference

18 August 2017

Jacques Guyotat

3

1 reference

18 August 2017

Marylin Barrie

4

1 reference

18 August 2017

Anne Jouvet

6

1 reference

18 August 2017

Olivier Chinot

7

1 reference

18 August 2017

Club de Neuro-Oncologie de la Société Française de Neurochirurgie and the Association des Neuro-Oncologues d'Expression Française

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

113

1 reference

18 August 2017

1

1 reference

18 August 2017

175-185

1 reference

Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age

18 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

The results of radiotherapy for ependymomas: the Mayo Clinic experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

Postoperative radiation therapy for grade II and III intracranial ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

A multicenter study of the prognosis and treatment of adult brain ependymal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Ependymomas: a clinicopathologic study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Intracranial ependymomas in adult patients: analyses of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

The clinical and prognostic relevance of grading in intracranial ependymomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Prognostic factors in intracranial ependymomas in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Long-term outcome in patients harboring intracranial ependymoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

The significance of radiotherapy treatment duration in intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Intracranial ependymomas: an analysis of prognostic factors and patterns of failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Is gross-total resection sufficient treatment for posterior fossa ependymomas?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Ependymoma: results, prognostic factors and treatment recommendations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Supratentorial ependymomas in adult patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Disseminated ependymomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Combined treatment of fourth ventricle ependymomas: report of 26 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23530

7 January 2021

Identifiers

DOI

10.1002/CNCR.23530

1 reference

18 August 2017

1 reference